# Ankyra Therapeutics

> Ankyra Therapeutics is a clinical-stage biotechnology company in Cambridge, Massachusetts developing "anchored" immunotherapies for cancer and immune-mediated diseases. Its platform tethers immune-modulating drugs to aluminum hydroxide so treatment concentrates at the disease site and minimizes systemic toxicity. Lead candidate ANK-101 is an anchored IL-12 therapy in clinical evaluation for advanced solid tumors. This is a company profile in the API Evangelist network; Ankyra publishes no developer API, SDK, or technical platform.

## Company
- [Website](https://ankyratx.com): Corporate site — platform, pipeline, team, and news.
- [Our Pipeline](https://ankyratx.com/our-pipeline/): Anchored immunotherapy pipeline including ANK-101 (anchored IL-12).
- [News](https://ankyratx.com/news/): Company press releases and announcements.
- [Join Our Team](https://ankyratx.com/our-team/join-our-team/): Careers.

## Contact
- Email: info@ankyratx.com
- Address: 245 Main St, Cambridge, MA 02142
- [LinkedIn](https://www.linkedin.com/company/ankyratx)
- [X / Twitter](https://twitter.com/ankyratx)

## APIs
No public developer API, SDK, MCP server, or machine-readable API description was found for Ankyra Therapeutics as of 2026-07-17. This profile exists for network discovery and enrichment only.